Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab

SB Bressler, H Qin, RW Beck, KV Chalam… - Archives of …, 2012 - jamanetwork.com
Objective To identify factors that predict the success or failure of treatment with intravitreal
ranibizumab for patients with diabetic macular edema. Methods A total of 37 baseline
demographic, systemic, ocular, optical coherence tomographic, and fundus photographic
variables were assessed for association with change in visual acuity or central subfield
thickness between baseline and 1 year in 361 eyes that were randomly assigned to
intravitreal ranibizumab with prompt or deferred laser treatment within a trial of ranibizumab …